Review
doi: 10.1136/jim-2021-002131.
Epub 2022 Jun 29.
Breakthrough SARS-CoV-2 infections after COVID-19 immunization
Affiliations
- PMID: 35768140
- DOI: 10.1136/jim-2021-002131
Item in Clipboard
Review
Breakthrough SARS-CoV-2 infections after COVID-19 immunization
J Investig Med.
2022 Aug.
Abstract
As no vaccines are 100% effective at preventing illness, COVID-19 vaccine breakthrough cases are expected. We here aim to review the most recent literature on COVID-19 vaccine breakthrough infections. SARS-CoV-2 breakthrough infections are, in general, rare. Age may still be a factor in SARS-CoV-2 infections in immunized individuals.
Keywords: COVID-19; viral vaccines.
© American Federation for Medical Research 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
COVID-19 vaccine efficacy in a rapidly changing landscape.J Investig Med. 2022 Aug;70(6):1327-1328. doi: 10.1136/jim-2022-002520. Epub 2022 Jun 29. J Investig Med. 2022. PMID: 35768142 No abstract available.
Similar articles
-
Breakthrough SARS-CoV-2 infections after vaccination: a critical review.Hum Vaccin Immunother. 2022 Nov 30;18(5):2051412. doi: 10.1080/21645515.2022.2051412. Epub 2022 Mar 18. Hum Vaccin Immunother. 2022. PMID: 35302905 Free PMC article. Review.
-
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.EBioMedicine. 2022 Jun;80:104042. doi: 10.1016/j.ebiom.2022.104042. Epub 2022 May 5. EBioMedicine. 2022. PMID: 35526306 Free PMC article.
-
Trends and Correlates of Breakthrough Infections With SARS-CoV-2.Front Public Health. 2022 May 10;10:856532. doi: 10.3389/fpubh.2022.856532. eCollection 2022. Front Public Health. 2022. PMID: 35619825 Free PMC article.
-
SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report.Hum Vaccin Immunother. 2022 Nov 30;18(5):2055947. doi: 10.1080/21645515.2022.2055947. Epub 2022 Apr 13. Hum Vaccin Immunother. 2022. PMID: 35417318 Free PMC article.
-
How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants.Front Public Health. 2022 Mar 15;10:842303. doi: 10.3389/fpubh.2022.842303. eCollection 2022. Front Public Health. 2022. PMID: 35372196 Free PMC article. Review.
Cited by
-
Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination.Front Immunol. 2024 Aug 29;15:1423766. doi: 10.3389/fimmu.2024.1423766. eCollection 2024. Front Immunol. 2024. PMID: 39267758 Free PMC article.
-
Humoral Immune Responses following COVID-19 Vaccinations among Adults in Tanzania.Vaccines (Basel). 2023 Dec 23;12(1):22. doi: 10.3390/vaccines12010022. Vaccines (Basel). 2023. PMID: 38250835 Free PMC article.
-
Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain.Viruses. 2023 Mar 30;15(4):886. doi: 10.3390/v15040886. Viruses. 2023. PMID: 37112865 Free PMC article.
-
Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant.Vaccines (Basel). 2022 Oct 16;10(10):1728. doi: 10.3390/vaccines10101728. Vaccines (Basel). 2022. PMID: 36298593 Free PMC article.
-
Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal.Vaccines (Basel). 2022 Dec 28;11(1):68. doi: 10.3390/vaccines11010068. Vaccines (Basel). 2022. PMID: 36679913 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
